Navigation Links
Christof von Kalle, M.D., Ph.D. receives Pioneer Award
Date:7/1/2014

New Rochelle, NY, July 1, 2014Christof von Kalle, MD, PhD (National Center for Cancer Research, Heidelberg, Germany) began his medical and research career with a focus on oncology and virology. He subsequently devoted much of his efforts to studying the use of viral vectors to deliver therapeutic genes into host cells and understanding the mechanisms of insertional mutagenesis. In recognition of his leadership and accomplishments, Dr. von Kalle has received a Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Human Gene Therapy is commemorating its 25th anniversary by bestowing this honor on the leading 12 Pioneers in the field of cell and gene therapy selected by a blue ribbon panel* and publishing a Pioneer Perspective by each of the award recipients. The Perspective by Dr. von Kalle is available on the Human Gene Therapy website.

In "Vector Integration and Tumorigenesis," Dr. von Kalle recalls his early experiences working with retroviral vectors and the growing body of knowledge that was developing about their ability to cause mutations at the sites where they integrated into the host cell genome. He discusses the teamwork, intensive research, and technology advances that led to a growing understanding of the link between vector insertion, mutation, and malignant transformation of cells. Tracing the progress of the field forward to the present and looking to the future, Dr. von Kalle comments on the revolutionary impact that next generation sequencing technologies, molecular tools and techniques, and omics studies are having on gene therapy.

"The level of sophistication that Dr. von Kalle has brought to the analysis of vector integration is truly remarkable," says James M. Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy, and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia. "This has established a solid scientific foundation to a critically important performance feature of retro- and lenti-based vectors."


'/>"/>

Contact: Kathryn Ruehle
kruehle@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. James Wilson, M.D., Ph.D. receives Pioneer Award
2. Huma Rana, M.D., receives 2014 Richard King Award for best publication, Genetics in Medicine
3. Xiangling Wang, M.D., Ph.D. receives Pfizer/ACMG Foundation Clinical Genetics Fellowship
4. Beth Israel Deaconess Medical Centers Harold F. Dvorak, M.D., wins Gairdner Award
5. JAX President and CEO Edison Liu, M.D., to receive Chen Award from HUGO
6. Ronald Crystal, M.D., receives Pioneer Award
7. Professor Sir David Weatherall, M.D., recieves 2013 Wallace H. Coulter Award
8. Frederic Bushman, Ph.D. receives Pioneer Award for advancing therapeutic gene delivery methods
9. Simon Levin, Ph.D., awarded prestigious 2014 Tyler Prize for Environmental Achievement
10. Jackson Laboratory researcher Gareth Howell, Ph.D., receives Lewis Rudin Glaucoma Prize
11. Joseph Glorioso, Ph.D., receives Pioneer Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Christof von Kalle, M.D., Ph.D. receives Pioneer Award
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)... 27. Februar 2017  EyeLock LLC, ein marktführendes Unternehmen ... erstklassige biometrische Lösung zur Iris-Erkennung auf der ... LTE auf dem Mobile World Congress 2017 ... in Halle 3, Stand 3E10, vorstellen. ... Qualcomm Haven™ – eine Kombination aus Hardware, ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... ... 22, 2017 , ... Researchers face a fundamental challenge as ... full-size tissues, bones, even whole organs to implant in people to treat disease ... into the developing tissue. , Current bioengineering techniques, including 3-D printing, can’t ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
(Date:3/22/2017)... 22, 2017 The global chronic ... research report by Transparency Market Research (TMR). The top ... and AbbVie Inc., accounted for a share of only ... in this market are focusing aggressively on mergers, acquisitions, ... is likely to lead to market consolidation in the ...
(Date:3/22/2017)... Mass. , March 22, 2017   Boston ... next-generation cancer therapeutics designed to target cancer stemness pathways, ... Patricia S. Andrews as Chief Executive Officer, effective ... succeed Chiang J. Li , M.D., FACP, who ... ten years ago. Under his leadership, Boston Biomedical has ...
Breaking Biology Technology: